Skip to contentM
Merit Medical Systems Inc
M
MMSIMerit Medical Systems Inc Q2 2023 · 10-Q
Revenue$320.06M$320.06M+8.5% vs Q2 2022 Net Income$20.25M$20.25M+32.3% vs Q2 2022 EPS Diluted$0.35$0.35+29.6% vs Q2 2022 Gross Profit$152,782,000+13.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Merit Medical Systems Inc · CIK 856982 · Engraved from SEC EDGAR
Operating Cash Flowderived$17,286,000−55.4% Free Cash Flowderived$11,515,000−63.5% Margins · derivedGross margin47.7%+1.9 pt vs Q2 2022
Operating margin9.0%+1.1 pt vs Q2 2022
Net margin6.3%+1.1 pt vs Q2 2022
ended Jun 30, 2023 · filed Jul 28, 2023 · 28 d after period end